PharmiWeb.com - Global Pharma News & Resources
10-Jul-2019

Embolic Protection Devices Market Size Poised to Touch USD 2 Bn by 2026

The global Embolic Protection Devices Market Size is estimated to grow at CAGR above 9.2% over the forecast time frame 2019 to 2026 and reach the market value around USD 2.0 billion by 2026.

Increasing cases of neurovascular surgeries and cardiovascular, also surges in heavy investments in research and development of embolic devices, are the main parameters pushing the embolic protection devices market development. Increase in numeral of (TAVR) Trans-catheter Aortic Valve Replacement procedures and consumer consciousness about embolic devices are also backing toward embolic protection devices market growth.

Increasing occurrences of neurovascular and cardiovascular diseases and rising acceptance of slightly invasive illnesses are pushing the embolic protection devices market development. Increasing need for technologically progressive embolic devices and growing healthcare spending, resulting in enormous finance and investments from multinational businesses, are driving the research and development in the worldwide medical devices industry. This parameter is also backing regarding the embolic protection devices market growth.

Wherein, the product disappointments and recalls might limit the embolic protection devices market development. Little reimbursement for stenting and occurrence of alternative treatment methods, for instance, the usage of drugs, might also impede the embolic protection devices market growth. Though, parameters for instance, an increase in the numeral of (TAVR) Trans-catheter Aortic Valve Replacement processes will support the embolic protection devices market development. The numeral of TAVR centers in U.S. has augmented from 156 in 2012 to 511 in 2017, and about 35,000 patients underwent TAVR in 2016 in U.S. alone. The distal obstruction systems sub-segment is anticipated to register the highest CAGR during the forthcoming years.

Download Report Sample Pages For Better Understanding at https://www.acumenresearchandconsulting.com/request-sample/982

Distal filter devices sub-segment developed as the largest segment due to growing need for these devices. Neurovascular diseases sub-segment captures for the largest share in the application segment due to the increasing cases of neurological illnesses.

Rising acceptance of slightly invasive surgeries and growing need for novel technologies are helping the dominance of this region. The market in the Asia Pacific is anticipated to observer swift development during the forthcoming years due to speedily improving healthcare infrastructure and huge targeted populace base.

Geographically, the embolic protection devices market is bifurcated into Europe, Asia Pacific, North America, MEA, and Latin America. North America, followed by Europe, is anticipated to capture the major share in the embolic protection devices market. This development is credited to increasing CVD cases, quick acceptance of latest technologies, and the occurrence of research and development centers. Asia Pacific is anticipated to observer lucrative during the forthcoming years crediting to investments from public and private entities, improvised healthcare infrastructure, increasing disposable income.

The global embolic protection devices market is segmented into product, application and region. On the basis of product the global Embolic protection devices market is segmented into distal occlusion filters, proximal occlusion filters, and distal filters. On the basis of application the global embolic protection devices market is segmented into neurovascular diseases, cardiovascular diseases, and peripheral vascular diseases. On the basis of region the global embolic protection devices market is segmented into Latin America, Europe, Asia Pacific, North America, and Middle East amp; Africa.

Asia Pacific is anticipated to observer the highest CAGR of 7.3% during the forecast timeframe. Growing heart related disease, rising healthcare spending, and growing disposable income are expected to increase the development of the regional embolic protection devices industry. North America captures the market in 2018 owing to increase in case of cardiovascular illness and constant launch of new product portfolio associated to embolic protection devices by main key players. Also, inventive marketing strategies being accepted by main key companies to encourage and embolic protection devices market and associated products are expected to inspire end users to accept these products, which in turn will stimulate the development of the regional market.

The key players catering to the global embolic protection devices market are Innovative Cardiovascular Solutions, LLC, Boston Scientific Corp., Gore Medical, Claret Medical, Inc., Medtronic Plc, Edward Lifesciences, Abbott Laboratories, Cardinal Health, Transverse Medical, Inc., and Allium Medical. The global players are continuously investing in Ramp;D and innovating new product portfolio to attract more and more business opportunity from the emerging nation such as India and China. Also, Increasing Ramp;D investments coupled with technological advancements to commercialise highly efficient products are anticipated to offer lucrative opportunities for industry participants.

View Detail Report at https://www.acumenresearchandconsulting.com/embolic-protection-devices-market

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Embolic Protection Devices
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Embolic Protection Devices Market By Product
1.2.2.1. Global Embolic Protection Devices Market Revenue and Growth Rate Comparison By Product (2015-2026)
1.2.2.2. Global Embolic Protection Devices Market Revenue Share By Product in 2017
1.2.2.3. Distal Occlusion Filters
1.2.2.4. Proximal Occlusion Filters
1.2.2.5. Distal Filters
1.2.2.6. Others
1.2.3. Embolic Protection Devices Market By Application
1.2.3.1. Global Embolic Protection Devices Market Revenue and Growth Rate Comparison By Application (2015-2026)
1.2.3.2. Global Embolic Protection Devices Market Revenue Share By Application in 2017
1.2.3.3. Neurovascular Diseases
1.2.3.4. Cardiovascular Diseases
1.2.3.5. Peripheral Vascular Diseases
1.2.3.6. Others
1.2.4. Embolic Protection Devices Market by Geography
1.2.4.1. Global Embolic Protection Devices Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.4.2. North America Embolic Protection Devices Market Revenue and Growth Rate (2015-2026)
1.2.4.3. Europe Embolic Protection Devices Market Revenue and Growth Rate (2015-2026)
1.2.4.4. Asia-Pacific Embolic Protection Devices Market Revenue and Growth Rate (2015-2026)
1.2.4.5. Latin America Embolic Protection Devices Market Revenue and Growth Rate (2015-2026)
1.2.4.6. Middle East and Africa (MEA) Embolic Protection Devices Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porterrsquo;s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Embolic Protection Devices Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Embolic Protection Devices Major Manufacturers in 2017
3.3. Ramp;D Status and Technology Source of Global Embolic Protection Devices Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Embolic Protection Devices Major Manufacturers in 2017

CHAPTER 4. EMBOLIC PROTECTION DEVICES MARKET BY PRODUCT

4.1. Global Embolic Protection Devices Revenue By Product
4.2. Distal Occlusion Filters
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Proximal Occlusion Filters
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Distal Filters
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Others
4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. EMBOLIC PROTECTION DEVICES MARKET BY APPLICATION

5.1. Global Embolic Protection Devices Revenue By Application
5.2. Neurovascular Diseases
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Cardiovascular Diseases
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Peripheral Vascular Diseases
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.5. Others
5.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. NORTH AMERICA EMBOLIC PROTECTION DEVICES MARKET BY COUNTRY

6.1. North America Embolic Protection Devices Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2. North America Embolic Protection Devices Market Revenue Share Comparison, 2015 amp; 2026 (%)
6.3. U.S.
6.3.1. U.S. Embolic Protection Devices Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
6.4. Canada
6.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
6.5. Mexico
6.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
6.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 7. EUROPE EMBOLIC PROTECTION DEVICES MARKET BY COUNTRY

7.1. Europe Embolic Protection Devices Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. Europe Embolic Protection Devices Market Revenue Share Comparison, 2015 amp; 2026 (%)
7.3. UK
7.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.4. Germany
7.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.5. France
7.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.6. Spain
7.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.6.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.7. Rest of Europe
7.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.7.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 8. ASIA-PACIFIC EMBOLIC PROTECTION DEVICES MARKET BY COUNTRY

8.1. Asia-Pacific Embolic Protection Devices Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Asia-Pacific Embolic Protection Devices Market Revenue Share Comparison, 2015 amp; 2026 (%)
8.3. China
8.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.4. Japan
8.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.5. India
8.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.6. Australia
8.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.7. South Korea
8.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.8. Rest of Asia-Pacific
8.8.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.8.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 9. LATIN AMERICA EMBOLIC PROTECTION DEVICES MARKET BY COUNTRY

9.1. Latin America Embolic Protection Devices Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Latin America Embolic Protection Devices Market Revenue Share Comparison, 2015 amp; 2026 (%)
9.3. Brazil
9.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.4. Argentina
9.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.5. Rest of Latin America
9.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 10. MIDDLE EAST EMBOLIC PROTECTION DEVICES MARKET BY COUNTRY

10.1. Middle East Embolic Protection Devices Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Middle East Embolic Protection Devices Market Revenue Share Comparison, 2015 amp; 2026 (%)
10.3. Saudi Arabia
10.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.4. UAE
10.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.5. Rest of Middle East
10.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 11. AFRICA EMBOLIC PROTECTION DEVICES MARKET BY COUNTRY

11.1. Africa Embolic Protection Devices Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Africa Embolic Protection Devices Market Revenue Share Comparison, 2015 amp; 2026 (%)
11.3. South Africa
11.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.4. Egypt
11.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.5. Rest of Africa
11.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

CHAPTER 12. COMPANY PROFILE

12.1. Innovative Cardiovascular Solutions, LLC
12.1.1. Company Snapshot
12.1.2. Overview
12.1.3. Financial Overview
12.1.4. Product Portfolio
12.1.5. Key Developments
12.1.6. Strategies
12.2. Boston Scientific Corp.
12.2.1. Company Snapshot
12.2.2. Overview
12.2.3. Financial Overview
12.2.4. Product Portfolio
12.2.5. Key Developments
12.2.6. Strategies
12.3. Gore Medical
12.3.1. Company Snapshot
12.3.2. Overview
12.3.3. Financial Overview
12.3.4. Product Portfolio
12.3.5. Key Developments
12.3.6. Strategies
12.4. Claret Medical, Inc.
12.4.1. Company Snapshot
12.4.2. Overview
12.4.3. Financial Overview
12.4.4. Product Portfolio
12.4.5. Key Developments
12.4.6. Strategies
12.5. Medtronic Plc
12.5.1. Company Snapshot
12.5.2. Overview
12.5.3. Financial Overview
12.5.4. Product Portfolio
12.5.5. Key Developments
12.5.6. Strategies
12.6. Edward Lifesciences
12.6.1. Company Snapshot
12.6.2. Overview
12.6.3. Financial Overview
12.6.4. Product Portfolio
12.6.5. Key Developments
12.6.6. Strategies
12.7. Abbott Laboratories
12.7.1. Company Snapshot
12.7.2. Overview
12.7.3. Financial Overview
12.7.4. Product Portfolio
12.7.5. Key Developments
12.7.6. Strategies
12.8. Cardinal Health
12.8.1. Company Snapshot
12.8.2. Overview
12.8.3. Financial Overview
12.8.4. Product Portfolio
12.8.5. Key Developments
12.8.6. Strategies
12.9. Transverse Medical, Inc.
12.9.1. Company Snapshot
12.9.2. Overview
12.9.3. Financial Overview
12.9.4. Product Portfolio
12.9.5. Key Developments
12.9.6. Strategies
12.10. Allium Medical
12.10.1. Company Snapshot
12.10.2. Overview
12.10.3. Financial Overview
12.10.4. Product Portfolio
12.10.5. Key Developments
12.10.6. Strategies
12.11. Others
12.11.1. Company Snapshot
12.11.2. Overview
12.11.3. Financial Overview
12.11.4. Product Portfolio
12.11.5. Key Developments
12.11.6. Strategies

CHAPTER 13. RESEARCH APPROACH

13.1. Research Methodology
13.1.1. Initial Data Search
13.1.2. Secondary Research
13.1.3. Primary Research
13.2. Assumptions and Scope

INQUIRY BEFORE BUYING: https://www.acumenresearchandconsulting.com/inquiry-before-buying/982

The report is readily available and can be dispatched immediately after payment confirmation.

Buy this Premium Research Report at https://www.acumenresearchandconsulting.com/buy-now/0/982

Would like to place an order or any question, please feel free to contact atsales@acumenresearchandconsulting.com| +1 407 915 4157

About Acumen Research and Consulting:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to makefact baseddecisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.

Editor Details

Last Updated: 10-Jul-2019